Compromised CDK1 activity sensitizes BRCA-proficient cancers to PARP inhibition.

Cells which might be poor in homologous recombination, resembling people who lack useful breast cancer-associated 1 (BRCA1) or BRCA2, are hypersensitive to inhibition of poly(ADP-ribose) […]

Compromised CDK1 activity sensitizes BRCA-proficient cancers to PARP inhibition. Read More